MedAccess partnered with IVCC and BASF to protect millions of lives by accelerating access to next-generation dual-action mosquito nets.

Public source

Publisher name

Public post

An important piece from IVCC (Innovative Vector Control Consortium) and its Director of Portfolio and Market Access, Mathias Mondy, on the urgent need to build the next…

Log in to read the full post

Company

MedAccess

Accelerating access to medical innovations

Industry
Public Health
Location
London, GB
Company size
51–200 employees

About MedAccess

We are a social enterprise committed to improving health in more than 115 countries. Our mission is to cut illness and death by speeding up access to lifesaving vaccines, medicines, diagnostics and technologies for people in underserved communities. Using $170 million capital from British International Investment, our agile team of global health and investment experts shapes agreements that break down the barriers preventing people from accessing medical innovations. We are independent and not-for-profit, with any operating surpluses invested into developing new agreements to accelerate access to healthcare.

See more

Latest activity

4 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.